CGT Catapult works closely with NHS through Accelerated Access Collaborative to offer pioneering cell and gene treatments

  • Published on 4th May 2022 by Cell and Gene Therapy Catapult

The Cell and Gene Therapy Catapult have been working closely with the NHS through the Accelerated Access Collaborative to expand access and support the NHS to offer two types of pioneering cell and gene treatments; Advanced Therapy Medicinal Products (ATMPs) and Histology Independent Therapies (HITs).

We have produced a short animation to celebrate the partnership achievements and the potentially life-changing treatments made available to patients. Watch here:

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.